Shares of Dermira Inc (NASDAQ:DERM) plunged hard Monday, after the drug maker announced negative Phase 3 data for its acne drug, DRM01, thus leading …
Dermira loses a bull after not one, but two pivotal studies of DRM01 in acne bombed.
Pyxis Tankers stock reached the $9 level for the first time ever, sending Maxim’s James Jang to the exit.
Square Inc (NYSE:SQ) has been Wall Street’s biggest standout of 2017, with shares skyrocketing nearly 260%. The biggest question for investors, then, is whether …
MannKind’s capital raise is not enough, says Jason Kolbert.
Wednesday turned out to be a nightmare for Otonomy Inc (NASDAQ:OTIC) investors, after the drug maker announced disappointing results from a pivotal Phase …
Standpoint Research Moves to Sidelines as DSW Delivers Upbeat Earnings
CoLucid Pharmaceuticals Inc CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are on the run today after the migraine-medicine maker announced a definitive merger agreement with Eli …
Cempra Inc (NASDAQ:CEMP) seen its shares falling nearly 9% (as of this writing), after analyst Ritu Baral of investment banking firm Cowen has downgraded CEMP …
In a research report released Friday, Needham analyst Alan Carr downgraded shares of Cempra Inc (NASDAQ:CEMP) from Buy to Hold rating, as he sees management …
